Brain angiotensin-II partially mediates the effects of relaxin on vasopressin and oxytocin release in anesthetized rats

Endocrinology. 1994 Mar;134(3):1188-92. doi: 10.1210/endo.134.3.8119158.

Abstract

Experiments were conducted in anesthetized rats to assess the contribution of the brain angiotensin-II system in the relaxin-induced secretion of vasopressin and oxytocin. Intravenous injection of porcine relaxin (5 micrograms) caused a significant (P < 0.05, by analysis of variance) increase in plasma concentrations of both hormones. Peak concentrations of both vasopressin (75.2 +/- 2.9 pmol/liter) and oxytocin (38.4 +/- 1.2 pmol/liter) were observed 1-2.5 min after relaxin injection. Thereafter, concentrations fell significantly (P < 0.05) but remained elevated for a further 25 minutes. Continuous infusion of a specific angiotensin-II receptor antagonist into the lateral cerebral ventricle did not affect baseline levels of either vasopressin or oxytocin, but did significantly reduce (P < 0.05) the relaxin-induced release of both peptides. A significant (P < 0.05) short term increase in both plasma vasopressin and oxytocin occurred 1 min after injection of 5 micrograms relaxin, iv, in angiotensin-II-antagonized rats, but the concentrations of both neuropeptides were significantly (P < 0.05) lower than those observed in the angiotensin-intact relaxin-treated controls. These data suggest that relaxin may act through the central angiotensin-II system to induce the release of vasopressin and oxytocin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthesia
  • Angiotensin II / physiology*
  • Animals
  • Brain / physiology*
  • Female
  • Oxytocin / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Relaxin / administration & dosage
  • Relaxin / pharmacology*
  • Vasopressins / metabolism*

Substances

  • Vasopressins
  • Angiotensin II
  • Oxytocin
  • Relaxin